In Vitro models for thrombogenicity testing of blood-recirculating medical devices

Abstract

Introduction: Blood-recirculating medical devices such as mechanical circulatory support (MCS), extracorporeal membrane oxygenators (ECMO), and hemodialyzers, are commonly used to treat or improve quality of life in patients with cardiac, pulmonary, and renal failure, respectively. As part of their regulatory approval, guidelines for thrombosis evaluation in preclinical development have been established. In vitro testing evaluates a device's potential to produce thrombosis markers in static and dynamic flow loops. Areas covered: This review focuses on in vitro static and dynamic models to assess thrombosis in blood-recirculating medical devices. A summary of key devices is followed by a review of molecular markers of contact activation. Current thrombosis testing guidance documents, ISO 10993-4, ASTM F-2888, and F-2382 will be discussed, followed by analysis of their application to in vitro testing models. Expert opinion: In general, researchers have favored in vivo models to thoroughly evaluate thrombosis, limiting in vitro evaluation to hemolysis. In vitro studies are not standardized and it is often difficult to compare studies on similar devices. As blood-recirculating devices have advanced to include wearable and implantable artificial organs, expanded guidelines standardizing in vitro testing are needed to identify the thrombotic potential without excessive use of in vivo resources during pre-clinical development.

Transient Neurovascular Interface for Minimally Invasive Neural Recording and Stimulation

“…Hemocompatibility is affected by the fabrication process since surface roughness strongly correlates to cell adhesion and platelet activation processes. [ 25 ] Smooth PCL, compared to electrospun mats, showed better interaction with blood. [ 26 ] Also, PCL‐based stents fabricated via 3D printing demonstrated good hemocompatibility.…”

Additive Manufacturing of NiTi Shape Memory Alloy for Biomedical Applications: Review of the LPBF Process Ecosystem

“…44 The lysis and thrombogenicity test is applied to check the tendency for clot formation due to an implanted NiTi material when exposed to blood. 45 Cytotoxicity testing using the methyl thiazol tetrazolium (MTT) assay is a quantitative chemical analysis to measure the metabolic activity of cells in response to an implanted material. 46 For corrosion resistance, potentiodynamic testing in Ringer's solution, 47 ASTM F21296 ''Standard Test Method for Conducting Cyclic Potentiodynamic Polarization Measurements to Determine the Corrosion Susceptibility of Small Implant Devices'', 48 and ASTM standard G5-14'' Standard Reference Test Method for Making Potentiodynamic Anodic Polarization Measurements'' are performed for NiTi material.…”

Control of Blood Coagulation by Hemocompatible Material Surfaces—A Review

“…Thrombus formation on blood-contacting medical devices is a complex process. Typically, the contact of foreign biomaterials with blood immediately leads to the adsorption of plasma proteins on the biomaterial surface [ 17 , 18 ]. This process takes place through physical interaction forces like Coulomb and van der Waals forces, hydrogen bonding, and hydrophobic interactions, leading to the reversible or irreversible adsorption of plasma proteins [ 19 ].…”

“…Overall, plasma protein adsorption is dependent on the character of the surfaces, such as their wetting properties and charge density [ 27 ]. In this regard, it is interesting to note that many plasma proteins have hydrophilic domains on their surface and a hydrophobic core [ 18 ]. However, epitopes with hydrophobic amino acids can also be located at the outer part of proteins driving adsorption on hydrophobic surfaces [ 27 ].…”